Search
for
Sort by
Research 661–690 of 1000+
- Polycystic Ovarian Syndrome
- <i>Polycystic Ovary Syndrome in Adolescence</i>
- The rationale for physiological testosterone replacement in women
- Prescribing testosterone and DHEA: The role of androgens in women
- How the stress of fight or flight turns hair white
- Unwanted hair.
- Postmenopausal Ovarian Hyperthecosis Associated with Rapid Testosterone Excess
- Retinol-binding protein 4, leptin, and insulin resistance in idiopathic hirsutism and hirsute women with polycystic ovary syndrome
- Management of Facial Hair in Women
- Assessment of the impact of VDR polymorphisms on selected hormonal, metabolic and mineral balance markers in young women with hyperandrogenism
- Management of women with hirsutism in Kosovo
- Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women—What Is the Evidence?
- Vitamin B-Complex and its Relationship with the Health of Vegetarian People
- SERUM PROLACTIN LEVELS IN WOMEN HAVING HIRSUTISM
- Exploring the role of Kantavallabha rasa in Polycystic ovarian syndrome management: A pilot Study
- Polycystic Ovary Syndrome: Management of a Long-Term Condition in Primary Care
- PCOS in Adolescence and Type 2 Diabetes
- Testosterone Therapy in Premenopausal Women
- Impact of Testosterone on Hair and Skin
- Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering
- Hormonal Therapy for Acne
- Review of Hair Follicle Dermal Papilla cells as <i>in vitro</i> screening model for hair growth
- Comparison of finasteride versus flutamide in the treatment of hirsutism
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- Androgens and hair loss
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- 5α-Reduced glucocorticoids: a story of natural selection
- Spinal and bulbar muscular atrophy: pathogenesis and clinical management
- ANDROGENETIC ALOPECIA
- Elevated serum androstenedione is associated with a more severe phenotype in women with polycystic ovary syndrome (PCOS)